Advance Search
Volume 38 Issue 5
May  2022
Turn off MathJax
Article Contents
DAI Meng-na, XI Yan, YIN Wen-qiang, . Trend in disease burden of leukemia in China, 1990 – 2019[J]. Chinese Journal of Public Health, 2022, 38(5): 539-546. doi: 10.11847/zgggws1135530
Citation: DAI Meng-na, XI Yan, YIN Wen-qiang, . Trend in disease burden of leukemia in China, 1990 – 2019[J]. Chinese Journal of Public Health, 2022, 38(5): 539-546. doi: 10.11847/zgggws1135530

Trend in disease burden of leukemia in China, 1990 – 2019

doi: 10.11847/zgggws1135530
  • Received Date: 2021-05-20
    Available Online: 2021-12-13
  • Publish Date: 2022-05-20
  •   Objective   To examine the disease burden of leukemia and its changing trend in China during 1990 – 2019 for providing a reference to strategy development of intervention and treatment of leukemia in China.   Methods   The data on leukemia incidence, mortality, and disability adjusted life year (DALY) in China were extracted from the database of the Global Burden of Disease Study 2019. Standardization was conducted for the incidence, mortality, and disability rate and Joinpoint regression model was adopted to analyze chronological trends in the standardized rates and to find meaningful turning points of the changing rates.   Results   The mortality, incidence rate and DALY of leukemia in China have been decreasing form 1990 to 2019. During the period for the standardized rates of leukemia, the mortality decreased averagely per year by 1.8% (1.5% for males and 2.2% for females), the incidence by 2.4 (2.1% for males and 2.2% for females), and the DALY by 1.8% (0.4% for males and 1.0% for females), respectively. The differences in the decreases of leukemia incidence, mortality and DALY rate were all statistically significant among general, male and female populations.   Conclusion   The disease burden of leukemia in China has decreased during 1990 – 2019, but the incidence rate has started to rebound. Under the influence of urbanization, industrialization and aging in China, the disease burden of leukemia may continue to increase, and it is necessary to strengthen researches on pathogenesis and risk factors of leukemia for developing effective intervention measures in high risk populations to slow down the increase in disease burden the disease.
  • loading
  • [1]
    王莉红, 吴铮, 闫蓓, 等. 上海市浦东新区2002 — 2012年白血病流行病学分析[J]. 中国公共卫生, 2016, 32(11): 1547 – 1550. doi: 10.11847/zgggws2016-32-11-26
    [2]
    Global Burden of Disease Collaborative Network. Global Burden of Disease Study 2019 (GBD 2019) results[EB/OL]. (2020 – 10 – 01) [2021 – 04 – 12]. http://ghdx.healthdata.org/record/ihme-data/gbd-2019-chewing-tobacco-use-prevalence-1990 – 2019.
    [3]
    李茜瑶, 周莹, 黄辉, 等. 疾病负担研究进展[J]. 中国公共卫生, 2018, 34(5): 777 – 780. doi: 10.11847/zgggws1118319
    [4]
    欧泽金, 余丹峰, 梁源浩, 等. 基于全球疾病负担研究数据分析1990至2017年白血病死亡和伤残调整生命年的变化趋势[J]. 癌症, 2021, 40(2): 69 – 81.
    [5]
    杨之洵, 陈万青. 癌症负担预测方法学的研究进展[J]. 中国肿瘤, 2019, 28(4): 241 – 245. doi: 10.11735/j.issn.1004-0242.2019.04.A001
    [6]
    沈秋明, 王洁, 李卓颖, 等. 上海市长宁区甲状腺癌发病率时间趋势分析[J]. 中国公共卫生, 2021, 37(4): 706 – 709. doi: 10.11847/zgggws1128023
    [7]
    Chen HS, Zeichner S, Anderson RN, et al. The joinpoint-jump and joinpoint-comparability ratio model for trend analysis with applications to coding changes in health statistics[J]. Journal of Official Statistics, 2020, 36(1): 49 – 62. doi: 10.2478/jos-2020-0003
    [8]
    李辉章, 杜灵彬. Joinpoint回归模型在肿瘤流行病学时间趋势分析中的应用[J]. 中华预防医学杂志, 2020, 54(8): 908 – 912. doi: 10.3760/cma.j.cn112150-20200616-00889
    [9]
    曾四清. Joinpoint回归模型及其在传染病流行趋势分析中的应用[J]. 中国卫生统计, 2019, 36(5): 787 – 791.
    [10]
    李莹, 李小燕, 燕虹, 等. 1991 — 2015年中国白血病死亡趋势APC模型分析[J]. 中华肿瘤防治杂志, 2019, 26(5): 285 – 289.
    [11]
    曾倩, 崔芳芳, 宇传华, 等. 中国癌症发病、死亡现状与趋势分析[J]. 中国卫生统计, 2016, 33(2): 321 – 323.
    [12]
    池家煌, 林艺兰. 2010 — 2014年厦门市居民白血病疾病负担量化测定研究[J]. 慢性病学杂志, 2016, 17(4): 374 – 376.
    [13]
    李芃泽, 房孙弘. 山东省1970 — 2013年居民白血病死亡率变化趋势分析[J]. 中华肿瘤防治杂志, 2020, 27(8): 590 – 595, 611.
    [14]
    Ou ZJ, Yu DF, Liang YH, et al. Analysis of the global burden of disease study highlights the trends in death and disability-adjusted life years of leukemia from 1990 to 2017[J]. Cancer Communications, 2020, 40(11): 598 – 610. doi: 10.1002/cac2.12094
    [15]
    Li BJ, Tang H, Cheng ZL, et al. The current situation and future trend of leukemia mortality by sex and area in China[J]. Frontiers in Public Health, 2020, 8: 598215. doi: 10.3389/fpubh.2020.598215
    [16]
    闫贻忠, 王文瑾, 李述刚, 等. 2016 — 2017年石河子市恶性肿瘤死亡及疾病负担情况分析[J]. 中国全科医学, 2019, 22(15): 1823 – 1829, 1835. doi: 10.12114/j.issn.1007-9572.2018.00.447
    [17]
    丁贤彬, 吕晓燕, 焦艳, 等. 2013 — 2018年重庆市儿童白血病发病死亡趋势分析[J]. 实用预防医学, 2021, 28(3): 292 – 295. doi: 10.3969/j.issn.1006-3110.2021.03.012
    [18]
    姜昊, 高艾. 环境污染与白血病关系的研究进展[J]. 环境与健康杂志, 2014, 31(7): 650 – 654.
    [19]
    Bawazir A, Al-Zamel N, Amen A, et al. The burden of leukemia in the Kingdom of Saudi Arabia: 15 years period (1999 – 2013)[J]. BMC Cancer, 2019, 19(1): 703. doi: 10.1186/s12885-019-5897-5
    [20]
    Shallis RM, Wang R, Davidoff A, et al. Epidemiology of acute myeloid leukemia: recent progress and enduring challenges[J]. Blood Reviews, 2019, 36: 70 – 87. doi: 10.1016/j.blre.2019.04.005
    [21]
    Bnaya A, Ruchlemer R, Itzkowitz E, et al. Incidence, risk factors, and recognition of pseudohyperkalemia in patients with chronic lymphocytic leukemia[J]. International Journal of Hematology, 2021, 114(1): 102 – 108. doi: 10.1007/s12185-021-03142-6
    [22]
    McKenzie LM, Allshouse WB, Byers TE, et al. Childhood hematologic cancer and residential proximity to oil and gas development[J]. PLoS One, 2017, 12(2): e0170423. doi: 10.1371/journal.pone.0170423
    [23]
    Ghazawi FM, Le M, Cyr J, et al. Analysis of acute myeloid leukemia incidence and geographic distribution in Canada from 1992 to 2010 reveals disease clusters in Sarnia and other industrial US border cities in Ontario[J]. Cancer, 2019, 125(11): 1886 – 1897. doi: 10.1002/cncr.32034
    [24]
    Wan ZY, Sun RZ, Moharil P, et al. Research advances in nanomedicine, immunotherapy, and combination therapy for leukemia[J]. Journal of Leukocyte Biology, 2021, 109(2): 425 – 436. doi: 10.1002/JLB.5MR0620-063RR
    [25]
    Hou HA, Tien HF. Genomic landscape in acute myeloid leukemia and its implications in risk classification and targeted therapies[J]. Journal of Biomedical Science, 2020, 27(1): 81. doi: 10.1186/s12929-020-00674-7
    [26]
    Boonhat H, Lin RT. Association between leukemia incidence and mortality and residential petrochemical exposure: a systematic review and meta-analysis[J]. Environment International, 2020, 145: 106090. doi: 10.1016/j.envint.2020.106090
    [27]
    Global Burden of Disease Cancer Collaboration. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 29 cancer groups, 1990 to 2016: a systematic analysis for the Global Burden of Disease Study[J]. JAMA Oncology, 2018, 4(11): 1553 – 1568. doi: 10.1001/jamaoncol.2018.2706
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(3)  / Tables(5)

    Article views (562) PDF downloads(116) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return